Idursulfase


Indications and Reactions:

Role Indications Reactions
Primary
Mucopolysaccharidosis Ii 34.3%
Premedication 15.7%
Cardiovascular Disorder 8.7%
Nervous System Disorder 8.6%
Product Used For Unknown Indication 6.7%
Gastrointestinal Disorder 5.3%
Pain 4.7%
Respiratory Disorder 4.2%
Sleep Disorder 2.9%
Convulsion 1.7%
Asthma 1.3%
Abnormal Behaviour 0.8%
Anxiety 0.8%
Constipation 0.7%
Hydrocephalus 0.7%
Bronchitis 0.6%
Hyperammonaemia 0.6%
Anticoagulant Therapy 0.5%
Cough 0.5%
Depression 0.5%
Death 14.2%
Pneumonia 9.4%
Infusion Related Reaction 7.1%
Respiratory Failure 7.1%
Urinary Tract Infection 7.1%
Thrombocytopenia 6.3%
Pyrexia 5.5%
Respiratory Distress 4.7%
Urticaria 4.7%
Vomiting 4.7%
Hospitalisation 3.9%
Lower Respiratory Tract Infection 3.9%
Nephrolithiasis 3.1%
Stridor 3.1%
Tracheal Stenosis 3.1%
Acute Respiratory Failure 2.4%
Device Related Infection 2.4%
Disease Progression 2.4%
Epilepsy 2.4%
Fluid Overload 2.4%
Secondary
Mucopolysaccharidosis Ii 22.1%
Premedication 15.2%
Cardiovascular Disorder 10.6%
Respiratory Disorder 10.6%
Pain 9.2%
Gastrointestinal Disorder 6.9%
Sleep Disorder 3.7%
Cough 2.8%
Wheezing 2.8%
Anti-infective Therapy 2.3%
Nervous System Disorder 1.8%
Abnormal Behaviour 1.4%
Bronchitis 1.4%
Cardiomyopathy 1.4%
Growth Retardation 1.4%
Hydrocephalus 1.4%
Infection 1.4%
Pain In Extremity 1.4%
Visual Acuity Reduced 1.4%
Blood Iron Decreased 0.9%
Abdominal Pain 9.8%
Lower Respiratory Tract Infection 9.8%
Catheter Site Infection 7.3%
Laryngeal Disorder 7.3%
Pneumonia 7.3%
Respiratory Distress 7.3%
Carpal Tunnel Syndrome 4.9%
Cellulitis Orbital 4.9%
Device Related Infection 4.9%
Mitral Valve Incompetence 4.9%
Respiratory Tract Infection 4.9%
Stridor 4.9%
Urticaria 4.9%
Death 2.4%
Device Leakage 2.4%
Fall 2.4%
Femur Fracture 2.4%
Foreign Body Aspiration 2.4%
Hydrocephalus 2.4%
Infusion Related Reaction 2.4%

Drug Data